1Zhao D, Liu J, Wang W, et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project[ J]. Stroke,2008, 39(6) : 1668-1674. 被引量：1
5CAST:randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischacmic stroke. CAST ( Chinese Acute Stroke Trial ) Collaborative Group [ J ]. Lancet, 1997,349 ( 9066 ) : 1641-1649. 被引量：1
6The International Stroke Trial(IST) :a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients witll acute ischaemic stroke. International Stroke Trial Collaborative Group [ J ]. Lancet, 1997,349 (9065) : 1569-1581. 被引量：1
7Algra A,van Gijn J. Aspirin at any dose above 30 mg of- fers only modest protection after cerebral ischaemia[ J ]. J Neurol Neurosurg Psychiatry, 1996,60 ( 2 ) : 197-199. 被引量：1
8CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischae- mic events (CAPRIE). CAPRIE Steering Committee[ J]. Lancet. 1996.348 ( 9038 ) :1329-1339. 被引量：1
9Hankey G J, Eikelboom JW. Antithrombotic drugs for pa- tients with ischaemic stroke and transient ischaemic at- tack to prevent recurrent major vascular events [ J ]. Lan- cet Neurol,2010,9 (3) :273-284. 被引量：1
10Kennedy J, Hill MD, Ryckborst KJ, et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER) :a randomised controlled pilot trim [ J ]. Lancet Neurol,2007,6 ( 1 l ) :961-969. 被引量：1
